Antigen clasping by two antigen-binding sites of an exceptionally specific antibody for histone methylation

Abstract

Antibodies have a well-established modular architecture wherein the antigen-binding site residing in the antigen-binding fragment (Fab or Fv) is an autonomous and complete unit for antigen recognition. Here, we describe antibodies departing from this paradigm. We developed recombinant antibodies to trimethylated lysine residues on histone H3, important epigenetic marks and challenging targets for molecular recognition. Quantitative characterization demonstrated their exquisite specificity and high affinity, and they performed well in common epigenetics applications. Surprisingly, crystal structures and biophysical analyses revealed that two antigen-binding sites of these antibodies form a head-to-head dimer and cooperatively recognize the antigen in the dimer interface. This "antigen clasping" produced an expansive interface where trimethylated Lys bound to an unusually extensive aromatic cage in one Fab and the histone N terminus to a pocket in the other, thereby rationalizing the high specificity. A long-neck antibody format with a long linker between the antigen-binding module and the Fc region facilitated antigen clasping and achieved both high specificity and high potency. Antigen clasping substantially expands the paradigm of antibody-antigen recognition and suggests a strategy for developing extremely specific antibodies.antibody engineering | epigenetics | antibody validation | protein-protein interaction | data reproducibility

Synthetic oligonucleotide antigens modified with locked nucleic acids detect disease specific antibodies

“…Another question is whether monoclonal antibodies are a true representation of the antibodies found in clinical samples. The selection of these antibodies may lead to a population of monoclonal antibodies that generally have a lower avidity towards DNA than is found for anti-DNA in sera 31 . Moreover, the constants are calculated using a 1:1 binding model, and it is debatable whether one can use this approximation, because antibodies have two binding sites 32 .…”

Windows of opportunity for Ebola virus infection treatment and vaccination

“…Afterwards, the B-cell proliferation and antibodies secretion can be summarized as where r Ab reflects the rate of antibody production, and δ Ab is the natural decaying rate of IgG, which is approximately 28 days 34 . The parameter β Ab = ρβ Ag denotes the removing rate of antibodies from binding with the antigens where ρ > 0 reflect potential varied stoichiometry in the antigen-antibody interaction 36 , 37 . Fitting the model Eqs ( 3 )–( 5 ) to the average IgG data of all subjects resulted in a classic antibody response picture, namely a lag phase follows by an exponential phase before reaching a plateau (Fig.…”

SHP2 Inhibition Abrogates Adaptive Resistance to KRASG12C-Inhibition and Remodels the Tumor Microenvironment ofKRAS-Mutant Tumors

“…SDS-PAGE showed that Fabs were >90% pure. Fab binding to targets was assessed by a bead binding assay, as described previously (84). Briefly, biotinylated Fabs were immobilized on Dynabeads M280 streptavidin, and then excess biotinbinding sites on streptavidin were blocked with biotin.…”